ProKidney is incorporated in the Cayman Islands
ProKidney went public in July 2022 through a business combination with Social Capital Suvretta Holdings Corp. III
ProKidney’s fiscal year ends December 31st.
ProKidney’s stock trades on the Nasdaq Capital Market under the symbol “PROK”
The transfer agent for our securities is Continental Stock Transfer & Trust Company.
Please contact Continental Stock Transfer & Trust Company
1 State Street, 30th Floor
New York, NY 10004-1561
212.509.4000 or 800.509.5586 or
cstmail@continentalstock.com
Please contact Continental Stock Transfer & Trust Company
1 State Street, 30th Floor
New York, NY 10004-1561
212.509.4000 or 800.509.5586 or
cstmail@continentalstock.com
ProKidney’s auditors are Ernst & Young
Our legal counsel is Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C
You can learn more about ProKidney at www.prokidney.com
You can view the latest news releases on our news page here.
You can view our SEC filings here.
Ethan Holdaway
ProKidney
ethan.holdaway@prokidney.com
Daniel Ferry
LifeSci Advisors
Daniel@lifesciadvisors.com